Status:

COMPLETED

Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)

Lead Sponsor:

Bristol-Myers Squibb

Collaborating Sponsors:

Sanofi

Conditions:

Congestive Heart Failure

Eligibility:

All Genders

60+ years

Phase:

PHASE3

Brief Summary

The purpose of this clinical research study is to learn if Irbesartan is superior to placebo in reducing mortality and cardiovascular morbidity in subjects with heart failure with preserved systolic f...

Eligibility Criteria

Inclusion

  • Male or female age \>= 60 years with current symptoms of heart failure consistent with New York Heart Association (NYHA) class II-IV
  • Left ventricular ejection fraction (LVEF) \> = 45%
  • Willing to provide written informed consent AND hospitalization for heart failure within the past 6 months OR various abnormalities in electrocardiogram, echocardiogram or chest x-ray indicating heart disease.

Exclusion

  • Acute myocardial infarction within 3 months;
  • Heart revascularization procedure within 3 months;
  • Hospitalization for angina within 3 months;
  • Other heart surgery
  • Life-threatening or uncontrolled arrhythmia
  • Subjects with an implantable cardioverter-defibrillator that has discharged in the past 3 months;
  • Stroke or surgery of the arteries in the brain within 3 months;
  • Serious lung disease which requires use of home oxygen.
  • Significantly low blood pressure
  • Significantly high blood pressure
  • Other known diseases that may limit life expectancy to \<3 years;
  • Known or suspected bilateral kidney artery narrowing;
  • Geographic or social factors making study participation and follow-up impractical.

Key Trial Info

Start Date :

June 1 2002

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2008

Estimated Enrollment :

4128 Patients enrolled

Trial Details

Trial ID

NCT00095238

Start Date

June 1 2002

End Date

July 1 2008

Last Update

April 7 2015

Active Locations (229)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 58 (229 locations)

1

Local Institution

Birmingham, Alabama, United States

2

Local Institution

Peoria, Arizona, United States

3

Local Institution

Tucson, Arizona, United States

4

Local Institution

Little Rock, Arkansas, United States